PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12972984::ACT039558

MAVP

Evidence text

Paper-level observation

10 μM MAVP showed no significant reduction in cell number... 30 μM MAVP exhibited marked anti-proliferative effects, showing statistically distinct differences from both control and 100 μM MAVP treatments (p < 0.05), thereby demonstrating a concentration-dependent anti-proliferative response (Fig. 1E-F).
textConfidence: medium

Assay observation

Activity
Anticancer
Subtype
Cytotoxic
Measure
percent_inhibition
Comparator
=
Raw observation
concentration-dependent anti-proliferative response; 30 μM MAVP exhibited marked anti-proliferative effects
Normalized measurement
=30
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
HUVEC
Assay method
Not reported by source
Sequence
MAGGGATWLPPR
Standardization
ready simple

Source publication

Targeting VEGFR2 inhibition within a spatially-confined conduit promotes nerve self-resolution and alleviates mechanical allodynia

Bioactive Materials · 2026

DOI 10.1016/j.bioactmat.2026.03.009 PMC12972984
Parent mention

Related peptide identities

PEPDIA-PLP-001965

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.